Cancer Archives

News and Trends 20 Nov 2015

Cinfa Biotech’s Biosimilar is on the Starting Block!

Recently launched Cinfa Biotech just treated the first subjects in a clinical trial with its biosimilar of Neulasta®! Cinfa Biotech just announced that the first subjects have been dosed in a clinical trial of B12019, a biosimilar version of Amgen’s Neulasta® (pegfilgrastim) to treat chemotherapy-induced neutropenia. Though chemotherapy is highly effective against cancer, it is […]

November 20, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 20 Nov 2015

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

This week we say farewell to Austria and head North-West, across the United Kingdom and land in the Emerald Isle, Ireland, where we arrive at our destination, Dublin. The capital city of Ireland is the home of the very famous Irish dry stout, Trinity College (plus its stunning library) and a nearly 900-year-old cathedral. It is […]

November 20, 2015 - 2 minutesmins - By Philip Hemme

frits ahlefeldt cellectis servier pfizer ucart leukemia1

News and Trends 19 Nov 2015

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

French Servier and Pfizer have already had independent partnerships with Cellectis on various R&D areas. But now the two have signed a joint partnership on Cellectis’s leading product UCART19 for blood cancer. This unusual move only further feeds the rumours of Pfizer’s potential future acquisition of Cellectis. As we’ve discussed before, Cellectis has moved most […]

November 19, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2015

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

Biotech is getting more and more about partnering rather than doing everything alone. Some conservative Pharmas, which worked to more of a ‘Silo model’, are now branching out in a more open approach; the last one being the Pharma company from the south-west of France Pierre Fabre. The company, named after its iconic founder Pierre Fabre, […]

November 19, 2015 - 3 minutesmins - By Philip Hemme

microbiome seres eligo flagship cancer evelo

News and Trends 17 Nov 2015

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

The Microbiome and Immuno-Oncology fields are hugely trendy in the Biotech Industry – and now a marriage between the two has finally occurred… The Microbiome field is still very new, with the launch of the US Human Microbiome Project just happening in 2008. Nonetheless, some start-ups are moving fast up the microbiome ranks, as well […]

November 17, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Nov 2015

What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

Before the end of the mRNA conference in Berlin, I had to interview Stephane Bancel, the French founding CEO of Moderna…one of the biggest deals in Biotech today. Moderna is the mRNA therapies companies from Cambridge/Boston (US), most famous for having raised over 900 million dollars in VC money. I met Stephane one and a […]

November 16, 2015 - 1 minutemin - By Philip Hemme

News and Trends 12 Nov 2015

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

I am still at the mRNA Convention in Berlin…and was invited for a second interview – this time with the ‘RNA People’, battling to be the first to get an mRNA Drug onto the Worldwide Market. I had a chat with Franz-Werner Haas, the Chief Corporate Office of CureVac. We talked a lot about this […]

November 12, 2015 - 1 minutemin - By Philip Hemme

diatoms neuroblastoma chemotherapy algae TUdresden biocube

News and Trends 11 Nov 2015

Using Algae and NanoTech to Kill Cancer: An Australian-German Collaboration

Algae diatoms are now being used to kill cancer! A new research paper on nano-particles from Adelaide (Australia) has worked with researchers at the Dresden University of Technology (TUD) to create an algae-encapsulated chemotherapy, as published in Nature. This is certainly exciting stuff. Diatoms are a type of microalgae that have a silica based ‘shell’, […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Nov 2015

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers. Now their phase I clinical trial of belinostat (trade name Beleodaq) combined with chemo for relapses in non-Hodgkin Lymphomas has shown an 89% response rate. Originally developed by TopoTarget (a biotech in Copenhagen) Belinostat is now under Onxeo’s portfolio (along […]

November 11, 2015 - 3 minutesmins - By Dani Bancroft

dani bancroft copenhaganen fugt algae transart fest

News and Trends 10 Nov 2015

What the FUGT? We tried the Algae Bar Beer for the TransArt Fest in Copenhagen!

We went to the TransArt Festival at the stunning ‘Dome of Visions‘ in Copenhagen on Friday. There, we met loads of scientists and members of the public who were just as entranced as us by the home-grown BioArt. After our blogger Julie covered the Fab Foundation’s ‘Biohacking’ movement last Monday, I was really intrigued by […]

November 10, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 9 Nov 2015

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford’s Adaptimmune has some surprisingly good results too. Adaptimmune is a British, Oxford-based immuno-oncolgy company. It held a massive IPO last year, raising up to €150M on the NASDAQ, and its CEO was interviewed by BIO (video here) where he seemed […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 6 Nov 2015

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

About 30%. That’s how Cellectis‘ NASDAQ stock price has jumped between the 4th and the 5th of November. But why? Basically, because of the first human success of their allogeneic CAR-T therapy! The Great Ormond Street Hospital (UK) treated a young patient with refractory relapsed Acute Lymphoblastic Leukemia (ALL) with Cellectis’ allogeneic UCART19 product candidate in June. To […]

November 6, 2015 - 2 minutesmins - By Jerome Topsent

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Cinfa Biotech’s Biosimilar is on the Starting Block!

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

Using Algae and NanoTech to Kill Cancer: An Australian-German Collaboration

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

What the FUGT? We tried the Algae Bar Beer for the TransArt Fest in Copenhagen!

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!